Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis
Abstract Background The purpose of this study was to compare the treatment efficacy and safety of re-irradiation (re-RT) using stereotactic ablative radiotherapy (SABR) and initial SABR for primary, recurrent lung cancer or metastatic lung tumor. Methods A retrospective review of the medical records...
Guardado en:
Autores principales: | Tae Hoon Lee, Dong-Yun Kim, Hong-Gyun Wu, Joo Ho Lee, Hak Jae Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca005cff378c4d6d829ee2f78befc8c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma
por: Yang Liu, et al.
Publicado: (2021) -
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
por: Jorgo Kliton, et al.
Publicado: (2021) -
Negative 18F-FET PET/CT in brain metastasis recurrence: a teaching case report
por: Samirah Alshehri, et al.
Publicado: (2021) -
Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
por: Yanhao Liu, et al.
Publicado: (2021) -
Late orbital metastasis from colon cancer complicated by multiple tumors in the breast, lung, liver, and spine
por: Kensaku Makino, MD, et al.
Publicado: (2022)